Trial Details

Not Recruiting
Basic Information
Clinical ID c3326
Identifier ISRCTN30255103
Trial Title Colorectal cancer screening by quantitative analysis of DNA isolated from exfoliated cells sampled from the surface of human rectal mucosa: A pilot study
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Colorectal cancer; inflammatory bowel disease Cancer Colorectal
Interventions This study was conducted with two distinct groups of participants: 1. Patients presenting colorectal symptoms (outpatient group) 2. Patients with clinical diagnosis of colorectal malignancies This pilot study did not follow a case-control pattern; the two groups were enrolled for different purposes. The outpatient group provided samples for prospective analysis of DNA scores in individuals with a range of colorectal conditions. Investigation of the known cancer group addressed possible differences between tumours of the proximal and distal colon. Interventions: Samples of exfoliated cells were collected from the surface of rectal mucosa using proctoscopy and a short (10 sec) inflation in the rectal cavity of a cell-collecting balloon. The procedure was minimally invasive and was completed within five minutes. The collected samples were assessed for DNA contents.
Participant Information
Sponsor Colonix Medical Ltd (UK)
City -
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -